NLRP3 is a strong aging node but still not clearly a universal longevity bottleneck

NLRP3 is a strong aging node but still not clearly a universal longevity bottleneck

''结论'': NLRP3 inflammasome suppression has real mouse lifespan/healthspan-positive signals, but current public evidence still does **not** justify upgrading it to a universal longevity bottleneck.

''关键原始证据'':
# PMID 31625260: ''NLRP3 inflammasome suppression improves longevity and prevents cardiac aging in male mice.''
# PMID 31975052: ''Blockade of the NLRP3 inflammasome improves metabolic health and lifespan in obese mice.''
# PMID 37487005: ''Inhibiting NLRP3 signaling in aging podocytes improves their life- and health-span.''
# PMID 39192596: ''The NLRP3 inhibitor Dapansutrile improves the therapeutic action of lonafarnib on progeroid mice.''

''审稿式判断'':
# 这些正例多数是 context-dependent：特定性别、特定组织、特定代谢背景或与其他药物联用。
# 因此，NLRP3 更像一个强的 inflammaging 放大节点，而不是已经被证明的全身总开关。
# 若要升级，至少还需要跨性别、跨组织、跨衰老背景的独立复现，以及与更上游入口的头对头比较。